Implication of the Dose of Mineralocorticoid Receptor Antagonist Following Transcatheter Edge-to-Edge Mitral Valve Repair.

JACC Asia · 2025 · PMC12426662 · PMID 40434334

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although it did not reach statistical significance, a higher dose of MRA tended to be associated with a greater cumulative incidence of the primary outcome (≥37.5 mg/d [n = 116] 46%, 25 mg/d [n = 206] 38%, and 12.5 mg/d [n = 51] 31%; P = 0.17).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.